← Leaderboards
Katherine T Murray
Vanderbilt University
$8,799,176
Attributed
$8,799,176
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $591.4K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,799,176 · 8
By mechanism
R01$7,890,203 · 5
P01$516,741 · 1
R21$391,640 · 1
M01$592 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Richard M Caprioli$30,630,395
- Alfred L George$44,065,377
- Mark E Anderson$21,768,068
- Jorge H Capdevila$6,372,994
- F Peter Guengerich$48,178,939
Others in their field
Top investigators on “Atrial Fibrillation”
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Dan M Roden · Vanderbilt University Medical Center$46,715,542
- Jane Wilkinson · Broad Institute, Inc.$38,181,500
- Stacey Gabriel · Massachusetts Institute Of Technology$34,637,180
- Mark J Daly · Broad Institute, Inc.$34,637,180
- Bruce M Psaty · University Of Washington$27,684,589
Research focus
Atrial FibrillationPotassium ChannelArrhythmiaBaseMorbidity - Disease RateProteinsNovel StrategiesHeart AtriumRisk FactorsLinkPredispositionInflammationTissuesMutantAmyloidMutationAlzheimer&AposCellsAtrial Natriuretic FactorCardiac Surgery ProceduresHeart Electrical ActivityGenesAgingGeneral Population
Grant awards (32)
Novel Pathophysiological Targets in Atrial Fibrillation Susceptibility$476,112
R01 · FY2020 · HL · contact PI
Novel Pathophysiological Targets in Atrial Fibrillation Susceptibility$518,326
R01 · FY2019 · HL · contact PI
Novel Pathophysiological Targets in Atrial Fibrillation Susceptibility$572,969
R01 · FY2018 · HL · contact PI
Novel Pathophysiological Targets in Atrial Fibrillation Susceptibility$14,071
R01 · FY2018 · HL · contact PI
Novel Pathophysiological Targets in Atrial Fibrillation Susceptibility$531,183
R01 · FY2017 · HL · contact PI
Preamyloid Oligomers and Susceptibility to Atrial Fibrillation$378,378
R01 · FY2014 · HL · contact PI
Preamyloid Oligomers and Susceptibility to Atrial Fibrillation$366,859
R01 · FY2013 · HL · contact PI
Azithromycin and Sudden Cardiac Death: Electrophysiologic Mechanisms$185,640
R21 · FY2013 · HL · contact PI
Preamyloid Oligomers and Susceptibility to Atrial Fibrillation$385,378
R01 · FY2012 · HL · contact PI
Azithromycin and Sudden Cardiac Death: Electrophysiologic Mechanisms$206,000
R21 · FY2012 · HL · contact PI
Preamyloid Oligomers and Susceptibility to Atrial Fibrillation$388,755
R01 · FY2011 · HL · contact PI
Preamyloid Oligomers and Susceptibility to Atrial Fibrillation$400,906
R01 · FY2010 · HL · contact PI
A Molecular Target for Atrial Fibrillation$357,938
R01 · FY2007 · HL · contact PI
A Molecular Target for Atrial Fibrillation$368,629
R01 · FY2006 · HL · contact PI
Molecular targets in atrial fibrillation$180,499
P01 · FY2006 · HL · contact PI
A Molecular Target for Atrial Fibrillation$377,500
R01 · FY2005 · HL
Molecular targets in atrial fibrillation$175,005
P01 · FY2005 · HL
A Molecular Target for Atrial Fibrillation$377,500
R01 · FY2004 · HL
Molecular Modulation of Cardiac Na+ Channel Function$339,750
R01 · FY2004 · HL
A Molecular Target for Atrial Fibrillation$377,500
R01 · FY2003 · HL
Molecular Modulation of Cardiac Na+ Channel Function$339,750
R01 · FY2003 · HL
Molecular Modulation of Cardiac Na+ Channel Function$339,750
R01 · FY2002 · HL
Molecular targets in atrial fibrillation$161,237
P01 · FY2002 · HL
GENETIC SUSCEPTIBILITY IN ACQUIRED LONG QT SYNDROME$0
M01 · FY2002 · RR
Molecular Modulation of Cardiac Na+ Channel Function$330,575
R01 · FY2001 · HL
VOLTAGE GATED CARDIAC POTASSIUM CHANNELS$174,382
R01 · FY2001 · HL
GENETIC SUSCEPTIBILITY IN ACQUIRED LONG QT SYNDROME$0
M01 · FY2001 · RR
GENETIC SUSCEPTIBILITY IN ACQUIRED LONG QT SYNDROME$0
M01 · FY2001 · RR
GENETIC SUSCEPTIBILITY IN ACQUIRED LONG QT SYNDROME$0
M01 · FY2001 · RR
HUMAN CARDIAC NA+ CHANNELS--EFFECTS OF PHOSPHORYLATION$304,690
R01 · FY2000 · HL
VOLTAGE GATED CARDIAC POTASSIUM CHANNELS$169,302
R01 · FY2000 · HL
GENETIC SUSCEPTIBILITY IN ACQUIRED LONG QT SYNDROME$592
M01 · FY2000 · RR